CIS's Krzeminski identifies potential risks of not forming and implementing an auditing and monitoring plan Media, PA, July 13, 2011 --(PR.com)-- Compliance Implementation Services (CIS), a leading ...

Drug manufacturers, wholesale distributors and pharmacies stepped up during the COVID-19 pandemic to preserve supply chain integrity. They were very particular about quality because the stakes were ...

The Board of Directors of Rx-360 announced today that the organization has launched it Audit Sharing Program - the collection and sharing of reports from audits conducted by individual member ...

Ensuring timely availability of medicines has become one of the toughest challenges in pharma today. While current tariffs on US imports have spared the pharma sector for now, ripple effects across ...

CHENGDU, China, Nov. 22, 2024 /PRNewswire/ -- On November 19, Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a subsidiary of BGM Group Ltd, welcomed a team of experts from Guilin Pharmaceutical ...

The International Pharmaceutical Excipients Council Federation, (IPEC Federation) has announced the availability of the revised IPEC Good Distribution Practices Audit Guide for Pharmaceutical ...

Pharmaceutical manufacturers need to avoid letting down their guard on supply chain integrity after a period of hyper-focus during the COVID-19 pandemic. That’s the view of Jim Fries, CEO of RX-360, ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for ...

HONG KONG, Feb. 18, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to ...

CEOs and executives of pharmaceutical, bio, and digital healthcare companies are set to appear at the National Assembly audit hearings. At the audits on the 12th and 13th involving the Ministry of ...

Ensuring timely availability of medicines has become one of the toughest challenges in pharma today. While current tariffs on US imports have spared the pharma sector for now, ripple effects across ...